Home › NDC Lookup › RxCUI directory › RxCUI 1736585

Dexrazoxane 250 MG Injection — RxCUI 1736585

Name: Dexrazoxane 250 MG Injection (RxCUI 1736585)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1736585 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1736585

Official nameDexrazoxane 250 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped11

Package NDCs mapped11

Reported Medicaid activity (SDUD)165 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Dexrazoxane Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Dexrazoxane is given to help protect your heart from damage caused by doxorubicin, the chemotherapy you're receiving. Doxorubicin is very effective against breast cancer, but over...
Why am I getting this medication along with my chemotherapy?
This is actually by design. Clinical research showed that starting dexrazoxane at the same time as your very first doxorubicin treatment can actually reduce how well the chemothera...
Why wasn't I given this from the very beginning of my chemo?

📖 Read our full Dexrazoxane Injection guide →

🕸️ Concept Web — How Dexrazoxane 250 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dexrazoxane 250 MG Injection RxCUI 1736585 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Dexrazoxane 42736 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dexrazoxane Injection 1736584 SCDF
- Dexrazoxane Injectable Product 1154547 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dexrazoxane 250 MG 1736583 SCDC

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dexrazoxane 250 MG SCDC · 1736583
Dexrazoxane Injection SCDF · 1736584
Dexrazoxane Injectable Product SCDG · 1154547

📦 FDA Products & Package NDCs

11 products · 11 package NDCs

11 package NDCs map to RxCUI 1736585 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9247-01	1 VIAL in 1 BOX (0143-9247-01) / 1 INJECTION, POWDER, LYOPH...	Dexrazoxane	Hikma Pharmaceuticals USA Inc.	2017-10-05
00143-9248-01	1 VIAL in 1 BOX (0143-9248-01) / 1 INJECTION, POWDER, LYOPH...	Dexrazoxane	Hikma Pharmaceuticals USA Inc.	2017-10-05
55150-0434-01	1 KIT in 1 PACKAGE (55150-434-01) * 25 mL in 1 VIAL, SINGL...	DEXRAZOXANE	Eugia US LLC	2016-05-12
55150-0434-02	1 KIT in 1 PACKAGE (55150-434-02) * 25 mL in 1 VIAL, SINGL...	DEXRAZOXANE	AuroMedics Pharma LLC	2016-05-12
55150-0437-01	1 KIT in 1 PACKAGE (55150-437-01) * 50 mL in 1 VIAL, SINGL...	DEXRAZOXANE	Eugia US LLC	2016-05-12
68083-0195-01	1 VIAL in 1 CARTON (68083-195-01) / 50 mL in 1 VIAL	Dexrazoxane	Gland Pharma Limited	2016-12-05
68083-0388-01	1 VIAL in 1 CARTON (68083-388-01) / 25 mL in 1 VIAL	Dexrazoxane	Gland Pharma Limited	2019-12-16
72205-0247-01	1 VIAL, SINGLE-DOSE in 1 CARTON (72205-247-01) / 25 mL in 1...	Dexrazoxane	Novadoz Pharmaceuticals LLC	2025-04-09
72205-0248-01	1 VIAL, SINGLE-DOSE in 1 CARTON (72205-248-01) / 50 mL in 1...	Dexrazoxane	Novadoz Pharmaceuticals LLC	2025-04-09
72266-0101-01	1 VIAL in 1 CARTON (72266-101-01) / 50 mL in 1 VIAL	Dexrazoxane	Fosun Pharma USA Inc.	2019-03-18
72266-0235-01	1 VIAL in 1 CARTON (72266-235-01) / 25 mL in 1 VIAL	Dexrazoxane	Fosun Pharma USA Inc.	2021-11-01

Observed labelers: Eugia US LLC (3) · AuroMedics Pharma LLC (2) · Fosun Pharma USA Inc. (2) · Gland Pharma Limited (2) · Hikma Pharmaceuticals USA Inc. (2) · Novadoz Pharmaceuticals LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1190	Dexrazoxane hcl injection	9	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.